“Plasmapheresis” : !! Clinical Uses, Potential Complications and Long-Term Health Effects !!

The rising awareness about the benefits of source plasma collection to save multiple patients in comparison to traditional whole blood collection is significantly transforming the overall blood collection industry, thereby driving the plasmapheresis market. In addition, significant evidence on the success rate of plasmapheresis in the immediate treatment of critically ill patients with many autoimmune diseases, hematologic, renal, and metabolic diseases; and favorable reimbursement policies for plasmapheresis procedure in these medical conditions are the major factors that have significantly impacted the development in plasmapheresis market.

Global Plasmapheresis MarketΒ is expected to reach USD 1,285.3 million by 2022, at a CAGR of 8.3% during the forecast period of 2017 to 2022.Β Following a comprehensive research on plasmapheresis and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, and opportunities, listed in the market insights segment. Increasing incidence of autoimmune diseases, increasing demand for source plasma from biopharmaceutical companies, favorable reimbursement policies for plasmapheresis proceduresare the key market drivers covered in the report which will support the industry growth in the forecast period. However, high cost of plasmapheresis devices and procedures, lack of awareness about plasmapheresis procedures, and side effects associated with plasmapheresis procedures are restraining the adoption of this market to certain extent.

The report further gives an extensive outlook on the various end users of plasmapheresis. These end users include biopharmaceutical companies, hospitals & clinics, and other end users. The end users segment further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use of plasmapheresis in these end users to improve overall treatment of autoimmune, hematologic, renal, and metabolic diseases.

π‘ͺπ’π’Šπ’„π’Œ 𝑯𝒆𝒓𝒆 𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑭𝒐𝒓 𝑷𝑫𝑭 ➑ https://bit.ly/3jJwKML

Β 

An exhaustive analysis of the geographical scenario of the industry for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa is included in the geographical analysis section. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The key players operating in the global plasmapheresis market are Asahi Kasei Corporation (Japan), Terumo Corporation (Japan), Baxter International Inc. (U.S.), B. Braun Melsungen AG (Germany), Kawasumi Laboratories Inc. (Japan), Kaneka Corporation (Japan), Β Β Β Β  Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Shanghai Dahua Medical Apparatus Co., Ltd. (China), and Infomed SA (Switzerland).

Scope of Plasmapheresis Market Report:

Market by Product:

  • Instruments
  • Disposables

Market by Technology:

  • Membrane Filtration
  • Centrifugation

Market by Application:

  • Source Plasma Collection
  • Therapeutic Plasmapheresis

Market by End User:

  • Biopharmaceutical Companies
  • Hospitals &Clinics
  • Others

Market by Geography:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • Middle-East & Africa

Comments are closed